Asia Pacific Endometriosis Market Size & Forecast by 2028

Asia Pacific Endometriosis Market Size, Share & Industry Trends Analysis Report By Type, By Treatment (Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others), By Distribution Channel, By Country and Growth Forecast, 2022 - 2028

Published Date: February-2023 | Number of Pages: 89 | Format: PDF | Report ID: KBV-13459

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Get in-depth analysis of the COVID-19 impact on the Asia Pacific Endometriosis Market

Market Report Description

The Asia Pacific Endometriosis Market would witness market growth of 12.5% CAGR during the forecast period (2022-2028).

Treatments exist that can lessen the disease's progression and improve symptoms. Treatments include painkillers like hormone supplements, ibuprofen, and paracetamol, and contraceptives, surgery to remove endometriosis tissue patches by cutting them out or by lasering (vaporizing) them, and an operation to remove all or some of the damaged organs.

The inability to conceive is one of the main effects of endometriosis. The patient might never be able to become pregnant (infertility). Having endometriosis surgically removed can increase a woman's chances of becoming pregnant. However, there is no assurance that they will be able to conceive after treatment. Endometriosis surgery could result in further complications. For instance, organ damage, hemorrhage, or infections. If surgery is advised, discuss the potential risks with the surgeon.

Due to a lack of menstrual awareness, restricted access to sanitary products, and a hostile school environment, girls may find it challenging to attend class. India's government and non-governmental organizations have created programs to minimize the difficulty of schoolgirls' menstruation (NGOs). This sought to identify barriers to menstruation management in schools and facilitators in three Indian states. The Indian government has established several programs to improve menstrual hygiene management (MHM) in schools, with assistance from a number of organizations, with the goal of enhancing knowledge about feminine hygiene and related diseases. It also plays a significant role in raising awareness among women regarding menstrual hygiene, well-being, and educational achievements. Women in this region experience a variety of menstrual issues, which inspires them to use femtech apps for efficient care. This will spur market expansion in the Asia Pacific region.

The China market dominated the Asia Pacific Endometriosis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $177.3 million by 2028. The Japan market is estimated to grow a CAGR of 11.8% during (2022 - 2028). Additionally, The India market would experience a CAGR of 13.2% during (2022 - 2028).

Based on Type, the market is segmented into Superficial Peritoneal Lesion, Endometriomas, and Others. Based on Treatment, the market is segmented into Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Endometriosis Market is Projected to reach USD 2.2 Billion by 2028, at a CAGR of 11.6%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, Abbott Laboratories, and Consilient Health Limited.

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Superficial Peritoneal Lesion
  • Endometriomas
  • Others

By Treatment

  • Oral Contraceptives
  • Gonadotropin-releasing hormone (GnRH) medicines
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Teva Pharmaceuticals Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Abbott Laboratories
  • Consilient Health Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Endometriosis Market Report 2022-2028

North America Endometriosis Market Report 2022-2028

Europe Endometriosis Market Report 2022-2028

LAMEA Endometriosis Market Report 2022-2028

Purchase Report


Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities